摘要
目的 探讨mTOR、eIF4E、4E-BP1在宫颈癌发生发展中的作用和相关性,为预后判断提供理论依据.方法 采用免疫组织化学SP法检测mTOR、eIF4E、4E-BP1在53例宫颈癌组织、15例宫颈上皮内瘤变组织和13例正常宫颈组织中的表达.结果 (1)mTOR、eIF4E和4E-BP1在宫颈癌组中的阳性表达显著高于正常组和CIN组(P<0.01),而后两组比较差异无统计学意义(P>0.05);(2)eIF4E表达与宫颈癌临床分期、淋巴结转移、病理分化程度和术后复发有关(P<0.01,P<0.01,P<0.05,P<0.05);(3)mTOR表达与宫颈癌术后复发显著相关(P<0.01);(4)4E-BP1表达与宫颈癌临床分期显著相关(P<0.01);(5)mTOR与eIF4E;mTOR与4E-BP1在宫颈癌中的阳性表达均呈显著正相关(P<0.01);(6)生存单因素分析mTOR、eIF4E、4E-BP1均与宫颈癌的预后有关(P<0.01,P<0.05,P<0.05).结论 mTOR、eIF4E、4E-BP1的高表达在宫颈癌发生发展中起重要作用,与预后不良有关.
Objective To investigate the effects of the expression of mTOR,eIF4E and 4E - BP1 in the development and advancement of cervix carcinoma, in order to provide some valuable evidences for prognosis. Methods The expression of mTOR,eIF4E and 4E - BP1 in tumor tissues of 53 patients with cervix carcinoma and 15 cases with cervical intraepithelial neoplasia(CIN) and 13 cases with normal cervical epithelium were detected by S - P immunohistochemieal technique. Results ( 1 ) The expression of mTOR,eIF4E and 4E - BP1 in tumor tissues were higher than those in CIN and normal cervical epithelial tissues (P 〈 0.01 ) , and there was no significant difference in mTOR、eIF4E and 4E - BP1 staining between normal cervical epithelium and CIN groups ( P 〉 0.05 ). ( 2 ) eIF4E positive - expression correlated significantly with disease stage ,metastasis of pelvic lymph node ( P 〈 0.01 ), tumor cell differentiation and recurrence (P 〈 0.05 ). (3) mTOR positive - expression was related to recurrence ( P 〈 0.01 ). ( 4 ) 4E - BP1 positive - expression correlated significantly with disease stage ( P 〈 0.01 ). ( 5 ) mTOR positive - expression correlated significantly with elF4E and 4E - BP1 ( P 〈 0.01 ). ( 6 ) The analysis of single factor revealed that the expression of mTOR,eIF4E and 4E - BP1 was significantly related with prognosis of patients(P 〈0.01 ,P 〈 0.05 ,P 〈 0.05 ). Conclusion The increased expression of mTOR,eIF4E and 4E -BP1 may play an important role in the development and progression of the cervical carcinoma,which is associated with poor prognosis.
出处
《实用肿瘤学杂志》
CAS
2011年第4期301-305,共5页
Practical Oncology Journal
基金
基金项目:卫生部科研基金子课题资助(WKJ2007-3-001)